RE:RE:yankee- you make a good pointSometimes research can be a simple process. Website of American Bladder Cancer society states:
Facts
In the United States there were approximately 535,000 men and women alive who had a history of cancer of the urinary bladder -- 395,000 men and 140,000 women.
I have no idea of how many of those would benefit from Urocidin. I just know that 535,000 is a lot bigger number than 10,000. And that is only the US number. And if 10,000 equates to $300m.....
Our company will indeed be looked at by big Pharma, although I still feel that they would be risk adverse to investing prior to approval. Excellent that management is shopping this around at this point.